# | Performance measure | Source |
---|---|---|
Diagnostic services | ||
Pathology report confirming malignancy | ||
Biomarker information | ||
Treatment services | ||
Surgery for women under age 70 with Stage I to III breast cancer within 60 days of date of diagnosis | Malaysian guideline [17] | |
Adjuvant multi-agent (combination) chemotherapy for women under age 70 with Stage I (T1c) to III ER/PR negative breast cancer within 120 days of date of diagnosis | ||
Radiation therapy for women under age 70 with Stage I to III breast cancer who had breast conserving surgery for breast cancer within 1 year (365 days) of date of diagnosis | ||
Radiation therapy for women under age 70 who had mastectomy for breast cancer with node + (four or more positive regional lymph nodes) within 1 year (365 days) of date of diagnosis | NAPBC [12] | |
Tamoxifen or Aromatase Inhibitor for women greater than age 17 with Stage I (T1c) to III ER or PR positive breast cancer within 1 year (365 days) of date of diagnosis | ||
Trastuzumab therapy for women greater than age 17 with Stage I (T1c) to III HER2 positive breast cancer within 1 year (365 days) of date of diagnosis |